Illumina, Inc.

NASDAQ

Market Cap.

11.27B

Avg. Volume

2.73M

Price

1W %

1M %

3M %

6M %

1Y %

YTD %

--

--

--

--

--

--

--

AI Generated Qualitative Analysis

AI

Your time is precious, so save it. Use AI to get the most important information from the business.

Learn about Illumina, Inc.

Illumina, Inc. News

Illumina, Inc. Quantitative Score

Overall Score

Business

Growth

Unlock

Business

Quality

Unlock

Stock

Value

Unlock

Price

Move

Price

Momentum

Unlock

Price

Stability

Unlock
Website screenshot
HealthcareMedical - Diagnostics & Research
illumina.com

About Illumina, Inc.

Illumina, Inc. provides sequencing and array-based solutions for genetic and genomic analysis. Its products and services serve customers in a range of markets enabling the adoption of genomic solutions in research and clinical settings for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments. The company provides instruments and consumables used in genetic analysis; and genotyping and sequencing services, instrument service contracts, and development and licensing agreements, as well as cancer detection testing services. Its customers include genomic research centers, academic institutions, government laboratories, and hospitals, as well as pharmaceutical, biotechnology, commercial molecular diagnostic laboratories, and consumer genomics companies. The company markets and distributes its products directly to customers in North America, Europe, Latin America, and the Asia-Pacific region, as well as sells through life-science distributors in various markets within Europe, the Asia-Pacific region, Latin America, the Middle East, and Africa. The company was incorporated in 1998 and is based in San Diego, California.

Illumina, Inc. Earnings & Revenue

Illumina, Inc. Financials

Table Compare

Compare ILMN metrics with:

   

Earnings & Growth

ILMN

None

EPS (TTM) YoY Growth

--

--

Revenue (TTM) YoY Growth

--

--

 

Valuation (TTM)

ILMN

None

Price/Earnings Ratio

--

--

Price/Sales Ratio

--

--

 

Profitability & Efficiency (TTM)

ILMN

None

Net Profit Margin

--

--

Return on Equity

--

--

 

Financial Health (TTM)

ILMN

None

Debt/Assets Ratio

--

--

Assets/Liabilities Ratio

--

--

 

Illumina, Inc. Income

Illumina, Inc. Balance Sheet

Illumina, Inc. Cash Flow

Illumina, Inc. Financials Over Time

Analysts Rating

Strong Buy

Buy

Hold

Sell

Strong Sell

Metrics Scores

MetricsScore
Discounted Cash FlowsBuy
Return on EquityStrong Sell
Return on AssetsStrong Sell
Debt/Equity RatioStrong Sell
Price/Earnings RatioStrong Sell
Price/Book RatioStrong Sell

Price Targets


Disclaimer: This 3rd party analysis information is for reference only and does not constitute investment advice.

Illumina, Inc. Valuation

Project future cash flows and get the intrinsic value per share.

Start valuation modeling

Historical Market Cap

Shares Outstanding

Illumina, Inc. Executives

NameRole
Mr. Jacob Thaysen Ph.D.Chief Executive Officer & Director
Dr. Steven Barnard Ph.D.Chief Technology Officer
Mr. Kevin Carl PegelsChief of Global Operations
Stephanie CamposPresident
Mr. Jakob WedelChief Strategy & Corporate Development Officer
NameRoleGenderDate of BirthPay
Mr. Jacob Thaysen Ph.D.Chief Executive Officer & DirectorMale19752.5M
Dr. Steven Barnard Ph.D.Chief Technology Officer1961974.91K
Mr. Kevin Carl PegelsChief of Global OperationsMale1968921.04K
Stephanie CamposPresident

--

Mr. Jakob WedelChief Strategy & Corporate Development OfficerMale1972

--

Illumina, Inc. Insider Trades

Date5 Apr
NameRollins Carissa
RoleSVP, Chief Information Officer
TransactionDisposed
TypeF-InKind
Shares113
Date28 Mar
NameMeister Keith A.
RoleDirector
TransactionAcquired
TypeA-Award
Shares625
Date31 Mar
NameUllem Scott B.
RoleDirector
TransactionAcquired
TypeA-Award
Shares229
Date28 Mar
NameMeister Keith A.
RoleDirector
TransactionDisposed
Type
Shares0
Date28 Mar
NameMeister Keith A.
RoleDirector
TransactionDisposed
Type
Shares368744
DateNameRoleTransactionTypeShares
5 AprRollins CarissaSVP, Chief Information OfficerDisposedF-InKind113
28 MarMeister Keith A.DirectorAcquiredA-Award625
31 MarUllem Scott B.DirectorAcquiredA-Award229
28 MarMeister Keith A.DirectorDisposed0
28 MarMeister Keith A.DirectorDisposed368744

Discover More

Streamlined Academy

Illumina, Inc.

NASDAQ

Market Cap.

11.27B

Avg. Volume

2.73M

Price

1W %

1M %

3M %

6M %

1Y %

YTD %

--

--

--

--

--

--

--

Illumina, Inc. News

Illumina, Inc. Quantitative Score

Overall Score

Business

Growth

Unlock

Business

Quality

Unlock

Stock

Value

Unlock

Price

Move

Price

Momentum

Unlock

Price

Stability

Unlock

Illumina, Inc. Earnings & Revenue

Illumina, Inc. Income

Illumina, Inc. Balance Sheet

Illumina, Inc. Cash Flow

Illumina, Inc. Financials Over Time

Illumina, Inc. Executives

NameRole
Mr. Jacob Thaysen Ph.D.Chief Executive Officer & Director
Dr. Steven Barnard Ph.D.Chief Technology Officer
Mr. Kevin Carl PegelsChief of Global Operations
Stephanie CamposPresident
Mr. Jakob WedelChief Strategy & Corporate Development Officer
NameRoleGenderDate of BirthPay
Mr. Jacob Thaysen Ph.D.Chief Executive Officer & DirectorMale19752.5M
Dr. Steven Barnard Ph.D.Chief Technology Officer1961974.91K
Mr. Kevin Carl PegelsChief of Global OperationsMale1968921.04K
Stephanie CamposPresident

--

Mr. Jakob WedelChief Strategy & Corporate Development OfficerMale1972

--

Illumina, Inc. Insider Trades

Date5 Apr
NameRollins Carissa
RoleSVP, Chief Information Officer
TransactionDisposed
TypeF-InKind
Shares113
Date28 Mar
NameMeister Keith A.
RoleDirector
TransactionAcquired
TypeA-Award
Shares625
Date31 Mar
NameUllem Scott B.
RoleDirector
TransactionAcquired
TypeA-Award
Shares229
Date28 Mar
NameMeister Keith A.
RoleDirector
TransactionDisposed
Type
Shares0
Date28 Mar
NameMeister Keith A.
RoleDirector
TransactionDisposed
Type
Shares368744
DateNameRoleTransactionTypeShares
5 AprRollins CarissaSVP, Chief Information OfficerDisposedF-InKind113
28 MarMeister Keith A.DirectorAcquiredA-Award625
31 MarUllem Scott B.DirectorAcquiredA-Award229
28 MarMeister Keith A.DirectorDisposed0
28 MarMeister Keith A.DirectorDisposed368744

Streamlined Academy

Website screenshot
HealthcareMedical - Diagnostics & Research
illumina.com

About Illumina, Inc.

Illumina, Inc. provides sequencing and array-based solutions for genetic and genomic analysis. Its products and services serve customers in a range of markets enabling the adoption of genomic solutions in research and clinical settings for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments. The company provides instruments and consumables used in genetic analysis; and genotyping and sequencing services, instrument service contracts, and development and licensing agreements, as well as cancer detection testing services. Its customers include genomic research centers, academic institutions, government laboratories, and hospitals, as well as pharmaceutical, biotechnology, commercial molecular diagnostic laboratories, and consumer genomics companies. The company markets and distributes its products directly to customers in North America, Europe, Latin America, and the Asia-Pacific region, as well as sells through life-science distributors in various markets within Europe, the Asia-Pacific region, Latin America, the Middle East, and Africa. The company was incorporated in 1998 and is based in San Diego, California.

AI Generated Qualitative Analysis

AI

Your time is precious, so save it. Use AI to get the most important information from the business.

Learn about Illumina, Inc.

Illumina, Inc. Financials

Table Compare

Compare ILMN metrics with:

   

Earnings & Growth

ILMN

None

EPS (TTM) YoY Growth

--

--

Revenue (TTM) YoY Growth

--

--

 

Valuation (TTM)

ILMN

None

Price/Earnings Ratio

--

--

Price/Sales Ratio

--

--

 

Profitability & Efficiency (TTM)

ILMN

None

Net Profit Margin

--

--

Return on Equity

--

--

 

Financial Health (TTM)

ILMN

None

Debt/Assets Ratio

--

--

Assets/Liabilities Ratio

--

--

 

Illumina, Inc. Valuation

Project future cash flows and get the intrinsic value per share.

Start valuation modeling

Analysts Rating

Strong Buy

Buy

Hold

Sell

Strong Sell

Metrics Scores

MetricsScore
Discounted Cash FlowsBuy
Return on EquityStrong Sell
Return on AssetsStrong Sell
Debt/Equity RatioStrong Sell
Price/Earnings RatioStrong Sell
Price/Book RatioStrong Sell

Price Targets


Disclaimer: This 3rd party analysis information is for reference only and does not constitute investment advice.

Historical Market Cap

Shares Outstanding

Discover More

A Practical Guide: How To Analyze Any Stock (With Examples)